van Doorn PA - Search Results

1

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.

Kuitwaard K, van Doorn PA, Bengrine T, van Rijs W, Baas F, Nagelkerke SQ, Kuijpers TW, Fokkink WR, Bunschoten C, Broers MC, Willemsen SP, Jacobs BC, Huizinga R. Kuitwaard K, et al. Among authors: van rijs w, van doorn pa. Eur J Neurol. 2021 May;28(5):1677-1683. doi: 10.1111/ene.14742. Epub 2021 Feb 6. Eur J Neurol. 2021. PMID: 33460483 Free PMC article.

2

Treatment of immune neuropathies.

Van Doorn PA, Garssen MP. Van Doorn PA, et al. Curr Opin Neurol. 2002 Oct;15(5):623-31. doi: 10.1097/00019052-200210000-00014. Curr Opin Neurol. 2002. PMID: 12352007 Review.

3

Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy.

Overeem S, Geleijns K, Garssen MP, Jacobs BC, van Doorn PA, Lammers GJ. Overeem S, et al. Among authors: van doorn pa. Neurosci Lett. 2003 Apr 24;341(1):13-6. doi: 10.1016/s0304-3940(03)00085-5. Neurosci Lett. 2003. PMID: 12676332

4

Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.

van Sorge NM, van den Berg LH, Geleijns K, van Strijp JA, Jacobs BC, van Doorn PA, Wokke JH, van de Winkel JG, Leusen JH, van der Pol WL. van Sorge NM, et al. Among authors: van der pol wl, van strijp ja, van den berg lh, van doorn pa, van de winkel jg. Ann Neurol. 2003 May;53(5):570-9. doi: 10.1002/ana.10503. Ann Neurol. 2003. PMID: 12730990

5

Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients.

Buljevac D, Verkooyen RP, Jacobs BC, Hop W, van der Zwaan LA, van Doorn PA, Hintzen RQ. Buljevac D, et al. Among authors: van der zwaan la, van doorn pa. Ann Neurol. 2003 Dec;54(6):828-31. doi: 10.1002/ana.10759. Ann Neurol. 2003. PMID: 14681894

6

Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.

Geleijns K, Jacobs BC, Van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA. Geleijns K, et al. Among authors: van rijs w, van doorn pa. J Neuroimmunol. 2004 May;150(1-2):132-8. doi: 10.1016/j.jneuroim.2004.01.003. J Neuroimmunol. 2004. PMID: 15081257

7

Treatment of chronic inflammatory demyelinating polyneuropathy.

van Doorn PA, Ruts L. van Doorn PA, et al. Curr Opin Neurol. 2004 Oct;17(5):607-13. doi: 10.1097/00019052-200410000-00011. Curr Opin Neurol. 2004. PMID: 15367865 Review.

8

Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.

Geleijns K, Laman JD, van Rijs W, Tio-Gillen AP, Hintzen RQ, van Doorn PA, Jacobs BC. Geleijns K, et al. Among authors: van rijs w, van doorn pa. J Neuroimmunol. 2005 Apr;161(1-2):183-9. doi: 10.1016/j.jneuroim.2004.12.001. J Neuroimmunol. 2005. PMID: 15748958

9

Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations.

Ruts L, van Koningsveld R, van Doorn PA. Ruts L, et al. Among authors: van koningsveld r, van doorn pa. Neurology. 2005 Jul 12;65(1):138-40. doi: 10.1212/01.wnl.0000167549.09664.b8. Neurology. 2005. PMID: 16009902

10

Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.

Kuijf ML, van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW, Hooijkaas H, Hop WC, Jacobs BC. Kuijf ML, et al. Among authors: van doorn pa. J Neurol Sci. 2005 Dec 15;239(1):37-44. doi: 10.1016/j.jns.2005.07.009. Epub 2005 Sep 8. J Neurol Sci. 2005. PMID: 16154154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page